Drug interactions: NAD+ supplements may interact with certain medications, such as blood thinners, blood pressure medications, or chemotherapy drugs
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
It helps improve the stability and effectiveness of skincare products while maintaining formulation quality
Recent research suggests that SCFAs, exercise-induced lactate, and specific pro-resolving lipid mediators (resolvins, maresins) might direct microglia and astrocytes to these protective phenotypes [140, 141]